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Considerable progresshas been made on the deveopment of a variety ofanalytic methods to aid in the carcinogenic
riskassociatedwitheposuretoboth 0cct landeiementlant AlU the developmentofthesemethods
hasbeenaccompaniedbyconsiderationofmany issues,therearemany areas whereadditionaleffortcouldbe
diectedfftheseanalical nethodsaretopibdethemostappot pin eisk.Theseis hwlide n
ofcombiungmultiplestudiestoobtai anover riske the a softheati d model, methodsof s ftion
amongcompeting modes, an atoftheeffectofdifferent measures ofexposure onthe estimateddose-response

















ment are tobeimproved, several statistical issues needtobead-
dressed. Thesetopicsrelate tothefollowing fivegeneral areas:
a)combiningdata acrossdifferentstudies; b)modelrobustness;
c) model discrimination; d) measurement ofexposure; and e)
problems ofscreening and surveillance. This paper discusses
each ofthese general areas as they relate to the three general
questions posed about risk assessment.




cent years. There are numerous papers that have addressed
methodology to assess risk for both case-control studies and
cohortstudies, andthesemethodologies incorporateadjustments
forpotential confounders (1-5). However, indeciding whether
an exposureresultsin anincrease inrisk, oneisoftenfacedwith
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synthesizinginformationfrommultiplestudies, whichinsome
casesappeartohaveconflictingresults. Partofthereasonforthe
appearance of conflicting conclusions relates to the over-
simplistic butwidely usedpracticeofinterpreting statistically
significant results (usuallyp . 0.05) as a positive study and
declaringresultswherep > 0.05 anegativestudy. Suchaprac-
ticeignorestheconceptofstatisticalpowerinhypothesestesting
as well as the elevated type I error in studies where there are
multiple hypotheses.
PIweristheprobabilityofdetectingatrueriskwhenoneex-
ists and is a function ofthe magnitude ofthe true risk and the
samplesize. Oftenstudiesdonothavesufficientsamplesizeto
detectamoderate risk. Forexample, inanegativestudyof518
workersexposedtotrichloroethylene(6), Rockette(7)calculated
apowerof0.81 associatedwith3-foldriskoflungcancerandof







menintheSoderbergprocess. Thepowerofdetectinga 100% in-
creaseinlungcancerformenemployedatleast20years inthis
job andprocess is0.32.
Although low power may result in failing to detect a car-
cinogenic riskforaspecific study, multipletestsofhypotheses
withinastudymayresultinfalselydeclaringrisk. Theprobabili-
tyof allselyrejectingatleastoneofmultiplehypothesesiscalled
the experimentwise error rate and is seldom addressed in
epidemiological studies. Rockette and Arena (9) demonstrate
thatusing a standardbattery of24categories ofmalignancy in
two standardized computer programs (10,11) often used in the
analysisofmortalitydatafromoccupationalcohortsledtoanex-
perimentwiseerrorrateof0.36, notthe0.05associatedwitheach
individual comparison.H. E. ROCKE77lE
Ifwe are to adequately synthesizedatafrommultiplestudies,
thetwoconceptsofpowerandmultiplecomparisonsmustbeap-
propriately addressed. Thepractice ofcombining results from
multiplestudiesisoftencalledmetaanalysis. Metaanalysisisnot
a new concept and has been widely used in the educational
researchand social scienceareas(12-15)andmorerecently inthe
health area (16-20). However, inthemedical andhealthscience
areas, most ofthe applications have been to synthesize results
from well-controlled studies(usually randomizedtrials), andthe
moredifficultapplicationtoepidemiologicalstudieshasreceived
less attention.
Some general issues related to meta analysis in epidemio-
logical studies have been discussed in several papers (21-24),
and more recently, methods of meta analysis been applied
to occupational data. Synthesis ofdata across studies to assess
cancer risks has been conducted for workers exposed to vinyl
chloride (25), lead (26), asbestos (27), benzene (28), and
aluminum workers (29). In the more general area ofenviron-
mental exposure, the effect ofpassive smoking onlung cancer
has been evaluated using a metaanalysis (30). Given the rapid
proliferation of meta analyses in related medical areas, it is
likely that there will be an increasing use in occupational
and environmental risk assessment. However, the application
of meta analysis to the medical area, even when restricted
to randomized trials, has its limitations (31-34), and in the
area of environmental epidemiology additional problems
occur.
Epidemiological studies have a greatervariability ofdesign.
Some studies are case-control studies, andthere areavarietyof
options for selecting the control group. Theproportionate mor-
tality study is an approach used in a substantial numberofoc-
cupational mortality studies. Using only deaths known to the
employer, the proportionofdeaths fromaspecific cause within
the group ofall causes is compared to the proportion within a
control group. The cohort study obtains risk estimates over a
designatedobservationperiodand may haveeitheraninternal or
external control. Theestimates ofriskobtained inthesevarious
types ofstudies, although related, are not mathematically the
same. Furthernore, differentcontrol groupsanddiffering infor-
mation on potential confounders may lead to substantially dif-
ferentbiasesinthe riskestimate. Greenland(23)hasdescribed
procedures to adjust for confounding when combining data
acrossepidemiological studies, butthemethods areapproximate
andhighlydependentonassumptionsthat cannotbeconfirmed
withtheamountofinformationusually available in apublished
report.
Statistical Models
The second general question posed in regard to risk assess-
ment relates toascertaining adose-responserelationship. The
determinationofadose-response curve iscloselyrelated tothe
othertwogeneralquestions onrisk weposedearlier. First, ex-
istenceofadose-responserelationshipprovidesfurtherconfir-
mation of the existence of risk because it is one of the
epidemiological criteriaoftenspecifiedfor acause-effect rela-
tionship(35). Secondly, ifthedose-response curve isascertained,
itprovidesusefulinformationtoestimatetheeffectoflimitingex-




or to provide information outside the range of the data. The
robustnessofthemodelmaydependuponthepurposeforwhich
it is used. It is likely that if one is simply trying to ascertain
whetherriskincreaseswithdoseandtheexactformofthedose
responseisnotspecified,thenthemodelmaystillberobustwith




extrapolationoutsidethe rangeofthedata is often aprocedure
that may result in poor estimates if the model is incorrectly
specified.
Inattempting toascertain riskfrom exposuresbelieved tobe
carcinogenic, a variety of models have been proposed from
which inferences relative to magnitude of the risk, biological
mechanisms, andextrapolationtolowdoses maybebased. The
goalofthispaperisnottoreview indetailvariouscancermodels.
InterestedreadersmayconsultreviewsbyWhittemoreandKeller
(36); Armitage (37); the work ofMoolgavkar and colleagues
(38-40), andanonmathematical summaryofthevarious com-
peting modelsby Chu (41).
Armitage(37)discussesthreegeneralclassesofmodels which
he feels are the main contenders for generally applicable
theories. Themultistagemodelanditsmodifications(42-45) is
basedontheassumptionthatacellbecomesmalignantonlyafter
going through k transitions. As the model has developed, the
transition ratesbetweensuccessive stages are notrequired tobe
equal, and at least one ofthe stages is assumed to be linearly
related to dose. Thus, the ith dose-related transition rate is
assumedtobeequaltoabackgroundtransitionrateplusthepro-
duct ofa constant, b, and the instantaneous dose rate at time t.
The constantb5 is called the potency parameter and represents
theincrease inthetransition rateperunitincreaseindose. This
model is oftencriticized for nothaving abiological basis since





itisformulatedas abirth-deathprocess. Thismodelviews car-
cinogenesis astheendresultofatwo-stage, irreversibleprocess.
Itassumesthatmalignanttumorsarisefrom asinglemalignant
progenitorcell and thatthetransformation ofsusceptible stem
cells tomalignancy isindependentofthetransformationofother
stem cells. The model incorporates mutation rates that sum-
marizethelikelihoodthatduringcelldivisionanonnalcellwill








papersby Pike(46) andPetoand Lee(47) wheretimeuntil oc-
currence of tumor in mice exposed to a constant dose of a
carcinogen was assumed to be a Weibull distribution. The
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occurrence oftumor was hypothesized as occurring when the
firstofalargenumberofpotentially malignantcellsculminates
inaclinicallydetectabletumor. Thedistributionoftimeuntiloc-
currence of tumor can be viewed as the distribution of the
minimumtimetoeventofalargenumberofindependent, iden-
tically distributed randomvariables representing thetimesun-
til occurrence oftumor from an individual cell. The Weibull
distribution wasselectedbecauseitisoneofthelimitingextreme
value distributions for the minimum-order statistic. This ap-
proachofmodeling timeuntiloccurrenceoftumorwas recent-
ly applied (48) to incidence data for breast, ovary, and en-




as well as makeusefuldecisions ofthebenefitofchange in ex-
posure. For the multistage model, Day and Brown (49) sum-
marizetheimpactofthespecificstageaffectedbythecarcinogen
ontheobservedbenefitwhentheexposureiseliminated. Ifdose










beusefulgeneralizations. However, ourfocus is nottoindicate
whatspecificmodifications mightbemadetoexisting statistical
models buttoaddress somestatistical issues ofamoregeneral





questions of importance are as follows: How robust is the
estimate of the potency parameter? How robust is the model
when extrapolating to low dose? How robust is the method of
assessing theeffectofcontrolling exposure?
Inthetwo-stage, dose-related, multistagemodel, ithasbeen
demonstratedthattheconfidenceintervalestimatesofthepoten-
cyparameterbasedonWald's statistic are notwellbehaved for
extremeparametervaluesbutthatthestandardmethodsofplac-
ingconfidenceintervalshavegoodcoverageandpowerproper-





thestandard statisticalapproach to summarize suchvariability
isaconfidenceintervalestimate,CrumpandHowe(53)notethat
theabsenceofregularityconditionssufficientforapplyingstan-







fects of removing an exposure from the general population.
These results represent a beginning in regard to investigating
variousaspectsofrobustness, butmoreworkneedstobedone.
Unfortunately, inassessingtheeffectoflowexposuretocancer
risk, even with further investigations the ability to supportthe
validity of our inference is limited by the inability to obtain
estimates ofthe effect oflow exposure from epidemiological
studies. The general shape ofthe dose-response curve at low





nonthreshold model appears to be the most widely accepted
methodofestimatingriskatlowexposure(55). Thelinearnon-
threshold model has been described within the context of a
modifiedmultistagemodelbyCrump(56). Theassumptionsim-
plicit in a model relative to the behavior ofthe dose-response
curveatlowexposuremayhaveasubstantialeffectonlow-dose
riskestimates. However, intheabsenceofsufficient empirical
observations, model selectionatlowdosemustbemadebased





models mayhavedifferentunderlying biological assumptions.
Anintegalpartoftheselectionofamodelentailsusingavailable
biologicaldatatoevaluatetheassumptionsmadeinthevarious




stage model of Moolgavkar and Knudson. Bogen suggests
changes to existing models that he believes may correct for
underestimates ofsmall increments of cancer risk that would
result if exponential growth is assumed (57). This continued
scrutinyofthebiologicalassumptionsisdesirableandwillpro-
bably continue. However, it is likely that all of the statistical
models posed will continue to be considered simplistic when
evaluated by a cell biologist in regard to explaining the com-
plicatedprocessofcarcinogenesis.
In conjunction with assessing the underlying biological
assumptions, moreworkcouldbedoneindeterminingwhichof





a large number ofepidemiological studies. Ideally, one might
developaformalstatisticalproceduretodiscriminatecompeting
models, and then with existing data sets, formally test which
modelbestfitsthedata. Simulationstudiescouldbeusedtosup-
plement such analysis to evaluate the power ofdiscrimination
among thevarious studies.
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Testing which oftwo specific models in a general class of
models is mostappropriate hasbeenappliedto selectbetween
additive and multiplicative models (58-59). The classical
likelhoodratiotestisawell-acceptedapproachandhasbeenap-
pliedto situationswherethetwocompetingmodelsarespecial
cases of a more general class of models. However, it is not
generallyrecognizedthatlikelihoodratioprocedureshavealso
been appliedto situations inwhichthetwomodelsbeingcom-
pared are not members of the same family. For example,
Dumonceaux andAntle(60) haveprovidedatestoflognormal
versustheWeibulldistributionusinglikelihoodratioprocedures.
Statistical procedures to compare competing models in car-
cinogenic risk assessment would be more complicated, but
development of even an approximate method to formally












Similarly, more investigation is needed to determine the sen-
sitivity ofthe inferences made fromthevarious models to dif-
ferentmethodsofcharacterizingdose(averageexposure, max-
imum exposure, cumulative exposure, etc.)
ScreeningandEarlyDetectionofRisk
One ofthe objectives ofpublic health is early detection of





more likely thatlargernumbersofindividuals will beexposed
by thetime ariskhasbeendetected, therehasbeenlittleeffort
toapplytheexistingstatisticalmethodsofsequentialanalysisto
detect risk earlier. Adopting such models would require
modificationstoincorporatetheconceptofdiseaselatencyand
appropriatecontroloftypeIerrorifmultiplediseasesarebeing
screened. Knowledge ofspecific factors that relate to risk of
diseasemay suggestevaluatingcertainsubsetsofworkersorin-
cluding data onpotential confounders sothat statistical power
may be increased. Ifsuch surveillance designs aredeveloped,
theycouldbeappliedtonewprocessesthatarebelievedtohave
thepotential for anelevated cancer risk.
Summary
Continued work is needed in comparing the biological
justification ofdifferent models, testing models on epidemio-
logical populations, and evaluating model robustness. Little
workhasbeendonetodevelopbetterme analysisforassessing
riskacrossepidemiological studies, todevelopmethods totest










ofthe models to large numbers ofdatabases, more simulation
studiestodeterminehowsensitivetheconclusionsaretomodel
inadequacy, andmore statistical theory toenablecomparisons
amongthedifferentcompeting models.
Inclosing,theareaofdevelopmentofmodelsforcarcinogenic
risk assessment should be viewed as many other developing
areas. It is unlikely that the models we are currently using to
describe themechanisms ofcancer will be the ones we would
select 10yearsfromnow. Nevertheless, recognizingdteselimita-
tionsdoesnotimplythatwediscardallthepresentapproaches.
ThefollowingquotationfromNemathwouldappearparticularly
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